The Network-Based Research Unit (NBRU) at the Michigan Institute for Clinical & Health Research (MICHR), working together with several regional and national research networks, has pivoted to work collaboratively on the Coronavirus pandemic by making COVID-19 patient data available to researchers.
Stories of Impact
MICHR to tackle goal of diversifying and improving research to speed therapies for benefit of all patients
COVID-19, Stories of Impact
A new groundbreaking study from the University of Michigan’s Center for Drug Repurposing (CDR) reveals several drug contenders already in use for other purposes—including one dietary supplement—that have been shown to block or reduce SARS-CoV-2 infection in cells.
The study, published recently in the Proceedings of the National Academy of Sciences, uses artificial intelligence-powered image analysis of human cell lines during infection with the novel coronavirus.
MICHR Funding, Funding & Grant Writing
Are you interested in positioning your interdisciplinary research team to be competitive for an external large-scale grant (e.g., NIH U- and P-series mechanisms)? If so, you’re encouraged to apply for $100,000 in funding and tailored research support available through the Accelerating Synergy Award.
Regulatory Support (MIAP)
In an effort to make access to experimental agents easier and more efficient, Transforming Expanded Access to Maximize Support and Study (TEAMSS) has published new recommended guidelines, templates, and resources for physicians and institutions seeking Expanded Access for their patients.
